Skip to main content
Esophagus and Gastrointestinal Tract Gastrointestinal Microbiota

Gastrointestinal Microbiota

Should we think twice when prescribing PPIs?

Proton pump inhibitors are among the most frequently prescribed drugs because of their efficacy in treating acid-related disorders, but attention should be given to the reported adverse effects.

Read more

Editor's Choice

Ultra-processed foods and obesity-related cancers

A growing body of evidence points to a significant link between overconsumption of UPFs and obesity-related cancers. What are the underlying biological mechanisms, and the key areas for future research and policy action? 

FMT fails to ReSScue GI symptoms in systemic sclerosis patients

Results of the double-blind phase 2 ReSScue trial show no gastrointestinal benefit of fecal microbiota transplantation in people with systemic sclerosis.

Gut failure as a cause and consequence of critical illness

Gut dysfunction is the first event in a cascade that leads to multiorgan dysfunction syndrome, and factors intrinsic to critical illness injure the gut. Learn more in this review from the tenth Perioperative Quality Initiative meeting.

Diabetic gastroenteropathy: a pan-alimentary complication

Diabetic gastroenteropathy frequently involves the entire gastrointestinal tract and associated exocrine organs. Explore the prevalence, clinical presentation, assessment, and treatment approaches.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Episode 9: The gut microbiome and CAR T-cell therapy

How do nutrition, supplements and antibiotics impact patient outcomes?

Recent research suggests that the gut microbiome could be an important modulator of response to CAR T-cell therapy in patients with hematologic cancers.

Prof. Marion Subklewe takes us through the latest evidence, highlighting the impact of antibiotics, nutrition, and dietary supplements, and discusses how to devise interventions to improve patient outcomes.

Prof. Marion Subklewe
Listen now
Podcast